Résultats de recherche
13 juin 2024 · MRNA. mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age...
15 juin 2024 · Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved...
Il y a 6 jours · The average MRNA stock price target is $143.19, implying 22.3% upside potential. The Takeaway: The Next-Gen Vaccine Is a Big Deal for Moderna. With public fears of COVID-19 in the rearview mirror...
Manchettes
Il y a 5 jours · Get real-time updates on Moderna, Inc. Common Stock (MRNA) stock quotes, trades, and more. Make informed investments with Nasdaq.
11 juin 2024 · A combination COVID-19-flu vaccine may be more effective in boosting immunity than two separate shots in some people, according to preliminary results released by Moderna on Monday. The release...
Il y a 4 jours · See the latest Moderna stock price and MRNA stock rating, related news, valuation, dividends and more to help you make your investing decisions.
Il y a 4 jours · Stock analysis for Moderna Inc (MRNA:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
